Clínica Medellín - Grupo Quirónsalud

Quick facts

Phase 2 pipeline

• Corticosteroid with or without colchicine · Oncology
  Glucocorticoid receptor agonist

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Clínica Medellín - Grupo Quirónsalud portfolio CI brief
• Clínica Medellín - Grupo Quirónsalud pipeline updates RSS

Related

• Sector hub: All tracked pharma companies